"10.1371_journal.pmed.1001300","plos medicine","2012-08-28T00:00:00Z","Shama D Ahuja; David Ashkin; Monika Avendano; Rita Banerjee; Melissa Bauer; Jamie N Bayona; Mercedes C Becerra; Andrea Benedetti; Marcos Burgos; Rosella Centis; Eward D Chan; Chen-Yuan Chiang; Helen Cox; Lia D'Ambrosio; Kathy DeRiemer; Nguyen Huy Dung; Donald Enarson; Dennis Falzon; Katherine Flanagan; Jennifer Flood; Maria L Garcia-Garcia; Neel Gandhi; Reuben M Granich; Maria G Hollm-Delgado; Timothy H Holtz; Michael D Iseman; Leah G Jarlsberg; Salmaan Keshavjee; Hye-Ryoun Kim; Won-Jung Koh; Joey Lancaster; Christophe Lange; Wiel C M de Lange; Vaira Leimane; Chi Chiu Leung; Jiehui Li; Dick Menzies; Giovanni B Migliori; Sergey P Mishustin; Carole D Mitnick; Masa Narita; Philly O'Riordan; Madhukar Pai; Domingo Palmero; Seung-kyu Park; Geoffrey Pasvol; Jose Peña; Carlos Pérez-Guzmán; Maria I D Quelapio; Alfredo Ponce-de-Leon; Vija Riekstina; Jerome Robert; Sarah Royce; H Simon Schaaf; Kwonjune J Seung; Lena Shah; Tae Sun Shim; Sonya S Shin; Yuji Shiraishi; José Sifuentes-Osornio; Giovanni Sotgiu; Matthew J Strand; Payam Tabarsi; Thelma E Tupasi; Robert van Altena; Martie Van der Walt; Tjip S Van der Werf; Mario H Vargas; Pirett Viiklepp; Janice Westenhouse; Wing Wai Yew; Jae-Joon Yim; Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB","Bureau of Tuberculosis, New York, New York, United States of America; A.G. Holley Hospital, Lantana, Florida, United States of America; University of Toronto, Toronto, Canada; Mayo Clinic, Rochester, Minnesota, United States of America; Montreal Chest Institute, McGill University, Montreal, Canada; The Dartmouth Center for Health Care Delivery Science, Hanover, New Hampshire, United States of America; Harvard Medical School, Boston, Massachusetts, United States of America; Partners in Health, Boston, Massachusetts, United States of America; University of New Mexico School of Medicine, Albuquerque, New Mexico, United States of America; WHO Collaborating Centre for TB and Lung Diseases, Care and Research Institute, Fondazione S. Maugeri, Tradate, Italy; Denver Veterans Affair Medical Center, Denver, Colorado, United States of America; Wan Fang Hospital, School of Medicine-Taipei Medical University, Taiwan; Médecins Sans Frontières, Capetown, South Africa; UC Davis School of Medicine, Davis, California, United States of America; National TB Control Program, Hanoi, Vietnam; International Union against Tuberculosis and Lung Disease, Paris, France; World Health Organization, Geneva, Switzerland; MRC Laboratories, Banjul, The Gambia; California Department of Public Health, Sacramento, California, United States of America; Instituto Nacional de Salud Pública, Mexico, Mexico; Albert Einstein College of Medicine, Bronx, New York, United States of America; Thailand MOPH & US CDC Collaboration, Bangkok, Thailand; National Jewish Health, Denver, Colorado, United States of America; University of California, San Francisco, San Francisco, United States of America; Korea Cancer Center Hospital, Seoul, Korea; Samsung Medical Center, Seoul, Korea; South African Medical Research Council, Pretoria, South Africa; Medical Clinic, Tuberculosis Center Borstel, Borstel, Germany; University Medical Center Groningen, Groningen, The Netherlands; Clinic of Tuberculosis and Lung Diseases, Riga, Latvia; Tuberculosis and Chest Services, Hong Kong; New York City Health and Mental Hygiene, New York, New York, United States of America; Tomsk Oblast Tuberculosis Dispensary, Tomsk, Russia; University of Washington, Seattle, Washington, United States of America; City Road Medical Centre, London, United Kingdom; Hospital F.J. Muñiz, Buenos Aires, Argentina; TB Center, Seoul, Korea; Imperial College London, London, United Kingdom; Universidad Autonoma Madrid, Madrid, Spain; Instituto de Salud del Estado de Aguascalientes, Mexico, Mexico; Tropical Disease Foundation, Makati City, Philippines; Instituto Nacional de Ciencias Médicas y de Nutrición Salvador Zubirán, Mexico, Mexico; Bactériologie-Hygiène – UPMC, Paris, France; Stellenbosch University, Stellenbosch, South Africa; Brigham and Womens Hospital, Boston, Massachusetts, United States of America; University of Ulsan College of Medicine, Seoul, Korea; Fukujuji Hospital, Tokyo, Japan; Instituto Nacional de Ciencias Médicas y de Nutrición Salvador Zubirán, Mexico, Mexico; University of Sassari, Sassari, Italy; Shaheed Beheshti Medical University, Tehran, Iran; Instituto Nacional de Enfermedades Respiratorias, Mexico, Mexico; National Institute for Health Development, Tallinn, Estonia; Center for Infectious Diseases-California Department of Public Health, Sacramento, California, United States of America; Grantham Hospital, Hong Kong; Seoul National University College of Medicine, Seoul, Korea","¶ All members of the Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB are the authors and are listed in the manuscript byline.","JR is a Consultant for bioMérieux. WWY has been indirectly sponsored to participate in International Conferences by GlaxoSmithKline and Pfizer in the last 3 years. CDM is on the Scientific Advisory Board for Otsuka pharmaceuticals development of OPC67683 (Delaminid), a new anti-TB compound. SK received salary support from the Eli Lilly Foundation as part of funding for the activities of Partners In Health by the Foundations MDR-TB Partnership. This funder was not involved in the study design; collection, analysis and interpretation of data; writing of the paper; and/or decision to submit for publication. The Partners In Health project in Tomsk received funding from Mr. Tom White, the Open Society Institute, the Bill and Melinda Gates Foundation, and the Global Fund to fight AIDS, Tuberculosis and Malaria. None of these funders were involved in the study design; collection, analysis and interpretation of data; writing of the paper; and/or decision to submit for publication. KD is an unpaid, volunteer member of the New Diagnostics Working Group (NDWG), formed of members of the Stop TB Partnership. The Secretariat of the NDWG is hosted by FIND (Foundation for New Innovative Diagnostics). JB was working as consultant for Otsuka Pharmaceutical for the implementation of clinical trial in Peru. JB was co PI of a NIH grant in Peru, Epidemiology of Tuberculosis. MP and GP are members of the Editorial Board of PLOS Medicine. All other authors have declared that no competing interests exist.","2012","08","Shama D Ahuja","SDA",73,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA
